CD4 and cancer: The γδT cells represent a minor lymphocyte population (about 0.5–16% of total CD3+ cells) and, when isolated from patients with cancers, efficiently killed tumour cell lines, played a role at antigen-presenting cells (APCs) and induced CD4+ and CD8+ T cell proliferation and cytotoxicity.